HRSA Issues Three 340B Policy Clarifications

by Admin | November 22, 2011 8:12 pm

November 22, 2011—The Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs (OPA) issued three documents[1] late yesterday clarifying its policies in three areas: manufacturer audits of 340B covered entities, procedures for allocating 340B-priced drugs in short supply, and the office’s “penny pricing” policy when the statutory 340B ceiling price formula yields a zero or negative price.

 
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)
Endnotes:
  1. issued three documents: http://www.hrsa.gov/opa/policyreleases.htm
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2011/11/hrsa-issues-three-340b-policy-clarifications/

Copyright ©2026 340binformed.org unless otherwise noted.